Zebley et al. [108] analyzed serial clinical samples from patients with ALL and revealed that CD8+ CD19 CAR-T cells underwent DNA methylation reprogramming after infusion, leading to depletion of cell differentiation. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.